IP Library › Assignment 026699/0351
Patent Assignment
Reel/Frame 026699/0351

Merger

Recorded: 2011-08-04 Pages: 23
Assignor
MANTICORE PHARMACEUTICALS, INC.
Executed: 2006-01-16
Assignee
INFLABLOC PHARMACEUTICALS, INC.
2150 WEST DAUNTLESS AVENUE, SUITE 101, SALT LAKE CITY, UTAH, 84116
Covered Property (1)
Cobalamin Conjugates for Anti-Tumor Therapy
Patent: 7,232,805 →
Application: 10/659,501 →
Publication: US 2005/0054607
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 3, 2004
From: WEINSHENKER, NED M.; WEST, FREDERICK G.; ARANEO, BARBARA A.; LI, WEIPING
To: MANTICORE PHARMACEUTICALS, INC.
Reel/Frame 015417/0791 →
License Dec 29, 2010
From: UNIVERSITY OF UTAH RESEARCH FOUNDATION; INFLABLOC PHARMACEUTICALS, INC.
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 025553/0582 →
Corrective Assignment to Correct the Assignor, Remove University of Utah Research Foundation as Assignor Previously Recorded on Reel 025553 Frame 0582. Assignor(S) Hereby Confirms the Transfer of Property Rights Made Between Inflabloc Pharmaceuticals, Inc. and Osiris Therapeutics, Inc.. Aug 4, 2011
From: INFLABLOC PHARMACEUTICALS, INC
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 026699/0236 →